Incyte Corporation
664Patents
603Active
664Granted
62Portfolio score
Filing activity: Feb 17, 1995 → Feb 27, 2024 · 66 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7598257B2 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | Chemistry; Metallurgy | 224 | Active |
| US8158616B2 | Azetidine and cyclobutane derivatives as JAK inhibitors | Emerging Cross-Sectional Technologies | 133 | Active |
| US7335667B2 | Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors | Chemistry; Metallurgy | 121 | Expired |
| US7834022B2 | Metabolites of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Chemistry; Metallurgy | 120 | Active |
| US8410265B2 | Processes for preparing JAK inhibitors and related intermediate compounds | Emerging Cross-Sectional Technologies | 112 | Active |
| US8722693B2 | Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Chemistry; Metallurgy | 110 | Active |
| US8486902B2 | Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Chemistry; Metallurgy | 106 | Active |
| US8765734B2 | Piperidin-4-yl azetidine derivatives as JAK1 inhibitors | Chemistry; Metallurgy | 104 | Active |
| US8604043B2 | 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors | Chemistry; Metallurgy | 103 | Active |
| US8691807B2 | Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors | Chemistry; Metallurgy | 102 | Active |
| US8716303B2 | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors | Chemistry; Metallurgy | 101 | Active |
| US8415362B2 | Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | Chemistry; Metallurgy | 100 | Active |
| US8309718B2 | 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors | Chemistry; Metallurgy | 100 | Active |
| US9181271B2 | Tricyclic fused thiophene derivatives as JAK inhibitors | Chemistry; Metallurgy | 92 | Active |
| US8933085B2 | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors | Chemistry; Metallurgy | 90 | Active |
| US8420629B2 | Azetidine and cyclobutane derivatives as JAK inhibitors | Emerging Cross-Sectional Technologies | 90 | Active |
| US8445488B2 | Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors | Chemistry; Metallurgy | 89 | Active |
| US8563541B2 | Azepine inhibitors of Janus kinases | Chemistry; Metallurgy | 88 | Active |
| US6645499B1 | Human ena/VASP-like protein splice variant | Emerging Cross-Sectional Technologies | 84 | Expired |
| US8530485B2 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | Chemistry; Metallurgy | 84 | Active |
| US8513270B2 | Substituted heterocycles as Janus kinase inhibitors | Human Necessities | 82 | Active |
| US9034884B2 | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors | Human Necessities | 82 | Active |
| US8822481B1 | Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Chemistry; Metallurgy | 81 | Active |
| US8829013B1 | Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | Chemistry; Metallurgy | 80 | Active |
| US8541425B2 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | Chemistry; Metallurgy | 80 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.